Trial intelligence / Profile preview

Hymovis vs Corticosteroids in Glenohumeral Osteoarthritis

NCT06043544Phase 4Completed

Sponsor
Concordia Hospital Rome
Start
May 2021
Primary completion
Nov 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of sodium hyaluronate in glenohumeral osteoarthritis, sponsored by Concordia Hospital Rome. Started May 2021; status: completed.

02

Drugs

sodium hyaluronate
03

Conditions

glenohumeral osteoarthritis

Beyond the preview

Go deeper on NCT06043544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06043544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call